These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12858342)
1. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. Kitazawa S; Kajimoto K; Kondo T; Kitazawa R J Cell Biochem; 2003 Jul; 89(4):771-7. PubMed ID: 12858342 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Kitazawa R; Kitazawa S Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression. Kitazawa S; Kitazawa R Biochem Biophys Res Commun; 2002 Apr; 293(1):126-31. PubMed ID: 12054573 [TBL] [Abstract][Full Text] [Related]
4. Modulation of mouse RANKL gene expression by Runx2 and vitamin D3. Kitazawa R; Mori K; Yamaguchi A; Kondo T; Kitazawa S J Cell Biochem; 2008 Dec; 105(5):1289-97. PubMed ID: 18814144 [TBL] [Abstract][Full Text] [Related]
5. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492 [TBL] [Abstract][Full Text] [Related]
6. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. Liu J; Yang H; Liu W; Cao X; Feng X J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D and bone. Suda T; Ueno Y; Fujii K; Shinki T J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524 [TBL] [Abstract][Full Text] [Related]
8. TNF-alpha expression is transcriptionally regulated by RANK ligand. Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the cytokine pattern of porcine bone marrow-derived cells treated with 1alpha,25(OH)D. Sipos W; Duvigneau JC; Schmoll F; Exel B; Hofbauer G; Baravalle G; Hartl RT; Dobretsberger M; Pietschmann P J Vet Med A Physiol Pathol Clin Med; 2005 Oct; 52(8):382-7. PubMed ID: 16176565 [TBL] [Abstract][Full Text] [Related]
10. Activated T lymphocytes support osteoclast formation in vitro. Horwood NJ; Kartsogiannis V; Quinn JM; Romas E; Martin TJ; Gillespie MT Biochem Biophys Res Commun; 1999 Nov; 265(1):144-50. PubMed ID: 10548505 [TBL] [Abstract][Full Text] [Related]
11. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309 [TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166 [TBL] [Abstract][Full Text] [Related]
13. RANKL expression is related to the differentiation state of human osteoblasts. Atkins GJ; Kostakis P; Pan B; Farrugia A; Gronthos S; Evdokiou A; Harrison K; Findlay DM; Zannettino AC J Bone Miner Res; 2003 Jun; 18(6):1088-98. PubMed ID: 12817763 [TBL] [Abstract][Full Text] [Related]
14. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856 [TBL] [Abstract][Full Text] [Related]
15. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
16. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis. Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909 [TBL] [Abstract][Full Text] [Related]
17. Regulation of osteoclastogenesis by gap junction communication. Matemba SF; Lie A; Ransjö M J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710 [TBL] [Abstract][Full Text] [Related]
18. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts. Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902 [TBL] [Abstract][Full Text] [Related]
19. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866 [TBL] [Abstract][Full Text] [Related]
20. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]